Drug intelligence / Profile preview

N-alpha-tosyl-L-arginine methyl ester

Development stage
Unknown
Lead developer
The Pennsylvania State University
Modality
Small Molecules
Administration
Intradermal
01

Overview

N-alpha-tosyl-L-arginine methyl ester (TAME) is a small molecule derivative of the amino acid L-arginine. In clinical research conducted by Penn State University, specifically in studies evaluating microvascular function in cancer survivors, it is utilized as a pharmacological probe to inhibit nitric oxide synthase (NOS). By locally administering TAME via microdialysis, researchers can block the production of nitric oxide and thereby isolate the nitric oxide-dependent component of vasodilation in response to stimuli such as acetylcholine. This allows for the assessment of endothelial function and cardiovascular health. Although TAME is also recognized in molecular biology as an inhibitor of the anaphase-promoting complex/cyclosome (APC/C) and certain proteases, its primary application in this specific clinical context is the investigation of microvessel reactivity.

Other names
L-Arginine, N2-((4-methylphenyl)sulfonyl)-, methyl esterTosyl-L-arginine methyl esterp-Tosyl-L-arginine methyl esterN-p-tosyl-L-arginine methyl ester
02

Targets

F2 (Thrombin)

Beyond the preview

Go deeper on N-alpha-tosyl-L-arginine methyl ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-alpha-tosyl-L-arginine methyl ester.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call